This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company. The contract, valued at $1,239,019.00, is a delivery order issued under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery Services Taiwan will provide NIAID with a range of preclinical infectious disease models, including bacterial infection models and models of antibiotic-resistant urinary tract infections, to support NIAID's biomedical research mission. The delivery order has a firm fixed price pricing structure and a period of performance through February 7, 2025. No set-aside designation was indicated for this award.
Generated 9/6/24, 9:33 AM